June 20, 2013
Lonza increases prices of niacin and niacinamide by 7%
press release
Basel, Switzerland-based Lonza, the provider of value chemical and biotech ingredients to the nutrition and agro markets, announces a 7% increase in the prices of feed grade niacin and feed grade niacinamide, forms of vitamin B3 worldwide.
The price increase will come into immediate effect for non-contract customers or as existing commitments permit. This increase follows its last increase of 9% announced in March.
Lonza's capabilities include large and small molecules, peptides, amino acids and niche bio-products for the pharmaceutical, healthcare and life science industries.
